Trimurthi has issued a formal notice for its Extraordinary General Meeting (EGM) scheduled for January 9, 2026, to seek shareholder approval for a preferential allotment of equity shares worth ₹15.00 crores. The board of directors had earlier approved the proposal on December 11, 2025.

EGM Details and Voting Process

The company will conduct the EGM through Video Conferencing/Other Audio-Visual Means (OAVM) at 3:30 P.M. on January 9, 2026, in compliance with MCA and SEBI circulars. The cut-off date for determining voting eligibility has been set as January 2, 2026.

Share Allotment Structure

The preferential issue involves 25,00,000 equity shares priced at ₹60.00 each, comprising a face value of ₹10.00 and premium of ₹50.00 per share. The allotment covers 40 investors across promoter group and non-promoter categories.

Major Investor Allocations

The largest individual allocation goes to non-promoter Venkata Ramana Reddy Mallela with 3,30,000 shares, followed by promoter group member Pavani Vupparapalli receiving 3,25,000 shares. Other significant allocations include promoter Venkata Rama Rao Bommaraju (2,00,000 shares) and Avinash Reddy Pandiri (1,20,000 shares).

Fund Utilization Plan

The company plans to utilize the raised funds for lab-scale technology transfer expenses, laboratory interior setup, procurement of equipment including bio-reactors, and essential consumables. Additional allocations include technical expert expenses, pre-operative costs, working capital requirements, and general corporate purposes.

Regulatory Compliance and Approvals

The preferential allotment requires shareholder approval through special resolution and compliance with SEBI (ICDR) Regulations, 2018. The company has appointed Bharat Khaniwal, Practicing Company Secretary (ACS-29035), as scrutinizer for the e-voting process. The relevant date for pricing determination has been fixed as December 10, 2025, with the minimum issue price calculated at ₹59.61 based on SEBI regulations.

Additional Business Item

The EGM agenda also includes confirmation of Ms. Sridevi Belide's appointment as Non-Executive Non-Independent Director. She was initially appointed as additional director on October 23, 2025, and holds an MBBS degree, bringing healthcare expertise to the board.

Key Points

• Trimurthi has closed its trading window
• A board meeting is scheduled to discuss fund-raising proposals
• The closure affects designated persons and their immediate relatives

Details

Trimurthi (ISIN: INE314I01036) has announced the closure of its trading window in compliance with regulatory requirements. This action precedes an upcoming board meeting where fund-raising proposals will be discussed.

Trading Window Closure

The trading window closure applies to all designated persons of the company and their immediate relatives. This measure is in line with the Securities and Exchange Board of India (SEBI) regulations, specifically the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Upcoming Board Meeting

The board of directors is set to convene to consider and evaluate various fund-raising proposals. The exact date of the meeting has not been disclosed in the available information.

Implications

The closure of the trading window is a standard practice to prevent insider trading and ensure fair market practices. It suggests that the company is preparing for significant financial decisions that could potentially impact its stock price.

Investor Considerations

Investors and market participants should note that:

1. No trading activity by insiders will be permitted during this period
2. The outcome of the board meeting could have a material impact on the company's financial structure
3. Any decisions regarding fund-raising will be communicated to the public following the board meeting

Stakeholders are advised to await official announcements from Trimurthi for further details on the fund-raising proposals and their potential impact on the company's future operations and financial position.